Yasin Shokrollahi

Yasin Shokrollahi, Jose Colmenarez, Wenxi Liu et al.

The rapid advancement of Artificial Intelligence (AI) has catalyzed revolutionary changes across various sectors, notably in healthcare. In particular, generative AI-led by diffusion models and transformer architectures-has enabled significant breakthroughs in medical imaging (including image reconstruction, image-to-image translation, generation, and classification), protein structure prediction, clinical documentation, diagnostic assistance, radiology interpretation, clinical decision support, medical coding, and billing, as well as drug design and molecular representation. These innovations have enhanced clinical diagnosis, data reconstruction, and drug synthesis. This review paper aims to offer a comprehensive synthesis of recent advances in healthcare applications of generative AI, with an emphasis on diffusion and transformer models. Moreover, we discuss current capabilities, highlight existing limitations, and outline promising research directions to address emerging challenges. Serving as both a reference for researchers and a guide for practitioners, this work offers an integrated view of the state of the art, its impact on healthcare, and its future potential.

Yasin Shokrollahi, Karina B. Pinao Gonzales, Elizve N. Barrientos Toro et al.

Accurate whole-cell and nuclear segmentation is essential for precision pathology and spatial omics, yet routine hematoxylin and eosin (H&E) staining provides limited cytoplasmic contrast, restricting analyses to nuclei. Multiplex immunofluorescence (mIF) facilitates precise whole-cell delineation but remains constrained by cost and accessibility. We introduce VitaminP, a cross-modal learning framework enabling whole cell segmentation from H&E images. By learning from paired H&E-mIF data, VitaminP transfers molecular boundary information from mIF to overcome cytoplasmic contrast in H&E, establishing cross-modal supervision as a general strategy for recovering missing biological structure. We train VitaminP on 14 public datasets covering 34 cancer types and over 7 million instances, integrating publicly available labels with extensive annotations generated in this study, forming one of the largest resources for segmentation. VitaminP outperforms four state-of-the-art methods and generalizes to unseen datasets, including an in-house dataset spanning 24 rare cancer types. We further developed VitaminPScope, an open-source platform providing an interface for scalable inference and enabling broad adoption.